Slough, UK, June 20 th 2023: Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin) has announced the UK launch of Beclu ® (beclometasone dipropionate) 100 micrograms (mcg) ...
The availability of Beclu pMDIs has the potential to provide cost savings for the NHS whilst being a certified carbon neutral inhaler as a result of carbon offsetting. 3 Following an independent Life ...